2 Clarke Drive
Suite 100
Cranbury, NJ 08512
© 2024 MJH Life Sciences™ and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.
Matthew J. Ellis, MD, PhD, professor of Oncology and Medicine at Baylor College of Medicine, discusses neoadjuvant endocrine therapy for patients with breast cancer.
Matthew J. Ellis, MD, PhD, professor of Oncology and Medicine at Baylor College of Medicine, discusses neoadjuvant endocrine therapy for patients with breast cancer.
Patients often present with a larger breast mass, which puts the patient at high-risk of systemic recurrence, explains Ellis.
There was a subset of patients who did not see positive results with neoadjuvant chemotherapy, allowing neoadjuvant endocrine therapy to be investigated to attempt to shrink the tumor.